GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » 3-Year Dividend Growth Rate

Beximco Pharmaceuticals (DHA:BXPHARMA) 3-Year Dividend Growth Rate : 36.90% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals 3-Year Dividend Growth Rate?

Beximco Pharmaceuticals's Dividends per Share for the three months ended in Mar. 2024 was BDT0.00.

The historical rank and industry rank for Beximco Pharmaceuticals's 3-Year Dividend Growth Rate or its related term are showing as below:

DHA:BXPHARMA' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 6.3   Med: 25   Max: 45.5
Current: 36.9

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Beximco Pharmaceuticals was 45.50% per year. The lowest was 6.30% per year. And the median was 25.00% per year.

DHA:BXPHARMA's 3-Year Dividend Growth Rate is ranked better than
84.42% of 321 companies
in the Drug Manufacturers industry
Industry Median: 9.7 vs DHA:BXPHARMA: 36.90

During the past 3 years, the average Dividends Per Share Growth Rate was 36.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Beximco Pharmaceuticals's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Beximco Pharmaceuticals's Dividend Yield % is 2.87%.

Good Sign:

Beximco Pharmaceuticals Ltd stock dividend yield is close to 10-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Beximco Pharmaceuticals's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's 3-Year Dividend Growth Rate falls into.



Beximco Pharmaceuticals 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Beximco Pharmaceuticals  (DHA:BXPHARMA) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Beximco Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 3.06
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Beximco Pharmaceuticals was 0.41. The lowest was 0.09. And the median was 0.19.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Beximco Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
BDT 3.5000002023-11-142023-11-132024-02-20Cash DividendannuallyBDT:BDT 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Beximco Pharmaceuticals's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=3.5/122.40
=2.86 %

Current Share Price is BDT122.40.
Beximco Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is BDT3.5.

During the past 13 years, the highest Dividend Yield of Beximco Pharmaceuticals was 3.11%. The lowest was 0.42%. And the median was 1.49%.

Good Sign:

Beximco Pharmaceuticals Ltd stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beximco Pharmaceuticals 3-Year Dividend Growth Rate Related Terms>


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines